January 3, 2017—The Obama administration has cleared the 340B civil monetary penalties for manufacturers and ceiling price regulations for publication in the Federal Register. … [Read more...]
The Top 10 340B Stories of 2016
December 21, 2016—The 340B program mega-guidance was the chief concern of 340B Informed readers for the second year in a row. In an exact repeat of 2015, four of this year’s 10 most-popular stories were about the guidance, including our top story of 2016. The mega-guidance’s status remains “pending review” at the White House Office of Management and Budget. But with … [Read more...]
Senate Dems to Trump: Let’s Reduce Drug Prices Together
December 20, 2016—Nineteen Senate Democrats have signed a letter to President-elect Trump outlining five ways he can fulfill his campaign pledge, which he repeated last week, to lower prescription drug prices. … [Read more...]
Grassley to Trump: Let’s Partner on Rising Drug Prices
December 15, 2016—Sen. Charles Grassley (R-Iowa) is urging President-elect Trump to work with Congress to deal with drug companies that game the system and engage in anti-competitive behavior. The Justice Department, meanwhile, has charged two drug company executives with conspiracy to fix prices, rig bids, and allocate customers, part of a broader investigation of white collar … [Read more...]
Congressional Chairmen Ask CMS: Were 340B Providers Overcharged for EpiPens?
December 12, 2016—House and Senate committee leaders want the Centers for Medicare & Medicaid Services to answer questions about its handling of the anaphylaxis rescue drug EpiPen by Dec. 20, including whether EpiPen’s misclassification as a generic drug for Medicaid rebate purposes caused hospitals and other healthcare providers in the 340B drug discount program to be … [Read more...]
Small Businesses Want Relief From High Drug Costs
December 12, 2016—Nearly 90 percent of small businesses that that provide health insurance to their employees think prescription drugs cost too much and 72 percent blame drug companies, a new survey shows. Sixty three percent say the market for prescription drugs is completely broken and needs a major overhaul. The survey by the group Small Business Majority found that drug … [Read more...]
Vermont Shines Light on Extreme Drug Price Hikes
December 7, 2016—One out of ten drugs that the state of Vermont pays for shot up in price 50 percent or more during the last five fiscal years, a new state study shows. … [Read more...]